Related references
Note: Only part of the references are listed.The Wistar-Kyoto rat model of endogenous depression: A tool for exploring treatment resistance with an urgent need to focus on sex differences
Samuel J. Millard et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2020)
Patterns of prenatal antidepressant exposure and risk of preeclampsia and postpartum haemorrhage
Kristin Palmsten et al.
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY (2020)
Prenatal Antidepressant Use and Risk of Adverse Neonatal Outcomes
Gretchen Bandoli et al.
PEDIATRICS (2020)
Perinatal exposure to fluoxetine increases anxiety- and depressive-like behaviours and alters glutamatergic markers in the prefrontal cortex and hippocampus of male adolescent rats: A comparison between Sprague-Dawley rats and the Wistar-Kyoto rat model of depression
Samuel J. Millard et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
What do we know about sex differences in depression: A review of animal models and potential mechanisms
Lei Ma et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Treatment resistant depression in women with peripartum depression
M. Soledad Cepeda et al.
BMC PREGNANCY AND CHILDBIRTH (2019)
Perinatal fluoxetine has enduring sexually differentiated effects on neurobehavioral outcomes related to social behaviors
Mary Gemmel et al.
NEUROPHARMACOLOGY (2019)
Perinatal fluoxetine prevents the effect of pre-gestational maternal stress on 5-HT in the PFC, but maternal stress has enduring effects on mPFC synaptic structure in offspring
Mary Gemmel et al.
NEUROPHARMACOLOGY (2018)
Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
Deborah S. Hasin et al.
JAMA PSYCHIATRY (2018)
Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism
Lily R. Aleksandrova et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2017)
The effects of maternal antidepressant use on offspring behaviour and brain development: Implications for risk of neurodevelopmental disorders
Samuel J. Millard et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Perinatal fluoxetine effects on social play, the HPA system, and hippocampal plasticity in pre-adolescent male and female rats: Interactions with pre-gestational maternal stress
Mary Gemmel et al.
PSYCHONEUROENDOCRINOLOGY (2017)
Behavioural outcomes of adult female offspring following maternal stress and perinatal fluoxetine exposure
Veronika Kiryanova et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Prenatal stress and early-life exposure to fluoxetine have enduring effects on anxiety and hippocampal BDNF gene expression in adult male offspring
Fabien Boulle et al.
DEVELOPMENTAL PSYCHOBIOLOGY (2016)
Fluoxetine normalizes the effects of prenatal maternal stress on depression- and anxiety-like behaviors in mouse dams and male offspring
Ali-Akbar Salari et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
To Cull or Not To Cull? Considerations for Studies of Endocrine-Disrupting Chemicals
Alexander Suvorov et al.
ENDOCRINOLOGY (2016)
Influence of maternal care on the developing brain: Mechanisms, temporal dynamics and sensitive periods
James P. Curley et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2016)
Developmental fluoxetine exposure increases behavioral despair and alters epigenetic regulation of the hippocampal BDNF gene in adult female offspring
Fabien Boulle et al.
HORMONES AND BEHAVIOR (2016)
Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research
Matthew E. Glover et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2016)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos et al.
NATURE (2016)
EFFECTS OF MATERNAL STRESS AND PERINATAL FLUOXETINE EXPOSURE ON BEHAVIORAL OUTCOMES OF ADULT MALE OFFSPRING
V. Kiryanova et al.
NEUROSCIENCE (2016)
Sex differences and similarities in depressive-and anxiety-like behaviour in the Wistar-Kyoto rat
Nikita N. Burke et al.
PHYSIOLOGY & BEHAVIOR (2016)
Stargazin Modulation of AMPA Receptors
Sana A. Shaikh et al.
CELL REPORTS (2016)
Considerations when quantitating protein abundance by immunoblot
Alicia A. McDonough et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2015)
Brain Structural Effects of Antidepressant Treatment in Major Depression
Nicola Dusi et al.
CURRENT NEUROPHARMACOLOGY (2015)
Why is depression more prevalent in women?
Paul R. Albert
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2015)
The cellular target of antidepressants
Nicholas J. Brandon et al.
NATURE NEUROSCIENCE (2015)
Anchoring and synaptic stability of PSD-95 is driven by ephrin-B3
Martin Hruska et al.
NATURE NEUROSCIENCE (2015)
Reducing the stress of drug administration: implications for the 3Rs
Sarah A. Stuart et al.
SCIENTIFIC REPORTS (2015)
Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?
Gerard Sanacora et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Sex differences in animal models of psychiatric disorders
N. Kokras et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex
W. Zhou et al.
EUROPEAN PSYCHIATRY (2014)
Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development
Andreea S. Pop et al.
PSYCHOPHARMACOLOGY (2014)
Learned helplessness and social avoidance in the Wistar-Kyoto rat
Hyungwoo Nam et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2014)
A neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy
Jeremy D. Coplan et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2014)
National trends in antidepressant medication treatment among publicly insured pregnant women
Krista F. Huybrechts et al.
GENERAL HOSPITAL PSYCHIATRY (2013)
Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia
Natalie Matosin et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species
Bridgette D. Semple et al.
PROGRESS IN NEUROBIOLOGY (2013)
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
Caroline A. Browne et al.
FRONTIERS IN PHARMACOLOGY (2013)
Chronic fluoxetine treatment and maternal adversity differentially alter neurobehavioral outcomes in the rat dam
Jodi L. Pawluski et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Therapeutic Potential of Metabotropic Glutamate Receptor Modulators
N. Hovelso et al.
CURRENT NEUROPHARMACOLOGY (2012)
Towards a glutamate hypothesis of depression An emerging frontier of neuropsychopharmacology for mood disorders
Gerard Sanacora et al.
NEUROPHARMACOLOGY (2012)
BEHAVIOURAL OUTCOMES OF PERINATAL MATERNAL FLUOXETINE TREATMENT
B. B. McAllister et al.
NEUROSCIENCE (2012)
ANTIDEPRESSANT-LIKE EFFECTS OF LOW KETAMINE DOSE IS ASSOCIATED WITH INCREASED HIPPOCAMPAL AMPA/NMDA RECEPTOR DENSITY RATIO IN FEMALE WISTAR-KYOTO RATS
Y. Tizabi et al.
NEUROSCIENCE (2012)
Treatment-resistant depression: therapeutic trends, challenges, and future directions
Khalid Saad Al-Harbi
PATIENT PREFERENCE AND ADHERENCE (2012)
PSD-95 Is Required to Sustain the Molecular Organization of the Postsynaptic Density
Xiaobing Chen et al.
JOURNAL OF NEUROSCIENCE (2011)
Fluoxetine during Development Reverses the Effects of Prenatal Stress on Depressive-Like Behavior and Hippocampal Neurogenesis in Adolescence
Ine Rayen et al.
PLOS ONE (2011)
Serotonin Transporter Occupancy in Rats Exposed to Serotonin Reuptake Inhibitors In Utero or via Breast Milk
Catherine F. Capello et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
Colleen M. Niswender et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression
Anteneh M. Feyissa et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Molecular dissociation of the role of PSD-95 in regulating synaptic strength and LTD
Weifeng Xu et al.
NEURON (2008)
Involvement of the mGluR1 receptor in hippocampal synaptic plasticity and associative learning in behaving mice
Cristina Gil-Sanz et al.
CEREBRAL CORTEX (2008)
Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder
Monica Beneyto et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Increasing use of antidepressants in pregnancy
William O. Cooper et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders
Monica Beneyto et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Differentiating antidepressants of the future: Efficacy and safety
Sharon Rosenzweig-Lipson et al.
PHARMACOLOGY & THERAPEUTICS (2007)
The use of behavioral test batteries, II: Effect of test interval
R Paylor et al.
PHYSIOLOGY & BEHAVIOR (2006)
Aqueous photochemical reaction kinetics and transformations of fluoxetine
MW Lam et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2005)
Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats
MR Thompson et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Prevalence of depression during pregnancy: Systematic review
HA Bennett et al.
OBSTETRICS AND GYNECOLOGY (2004)
Effects of chronic fluoxetine in animal models of anxiety and depression
SC Dulawa et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Maternal behavior modulates X-linked inheritance of behavioral coping in the defensive burying test
N Ahmadiyeh et al.
BIOLOGICAL PSYCHIATRY (2004)
PDZ domain proteins of synapses
EJ Kim et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Prevalence and development of psychiatric disorders in childhood and adolescence
EJ Costello et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation
T Heikkinen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Selectively bred Wistar-Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants
CC Will et al.
MOLECULAR PSYCHIATRY (2003)
Amplified behavioral and endocrine responses to forced swim stress in the Wistar-Kyoto rat
PA Rittenhouse et al.
PSYCHONEUROENDOCRINOLOGY (2002)
Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk
V Hendrick et al.
BIOLOGICAL PSYCHIATRY (2001)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Pharmacokinetics of selective serotonin reuptake inhibitors
C Hiemke et al.
PHARMACOLOGY & THERAPEUTICS (2000)
Share Paper
